ASTHO Statement on FDA’s Announcement to Reduce Nicotine in Cigarettes ARLINGTON, VA—ASTHO’s chief medical officer, Marcus Plescia, issued the following statement on FDA’s announcement to reduce ...
On Aug. 11, 2022, ASTHO's Chief Medical Officer issued a statement of support for CDC's new COVID-19 guidelines.
On Feb. 26, 2024, ASTHO's CMO issued a statement in response to several measles outbreaks currently occurring in the United States.
ASTHO Urges Increased Investment to Address Growing Obesity Epidemic ARLINGTON, VA—Obesity rates in the United States are on the rise, according to new reports from CDC and Trust for ...
ASTHO Urges Broad Tobacco Control Policies to Stop Youth E-Cigarette Use ARLINGTON, VA—New CDC data finds that more high school and middle school students are using tobacco products and that ...
On Oct. 13, 2022, ASTHO CMO Marcus Plescia released a statement supporting ACIP's decision to encourage adding COVID-19 vaccinations to standard immunization schedules.
On August 9, 2022, ASTHO Chief Medical Officer Marcus Plescia, MD, MPH, released a statement on the declaration of monkeypox as a national public health emergency.